Calliditas Therapeutics (DE:LC8A)
FRANKFURT:LC8A
Holding DE:LC8A?
Track your performance easily

Calliditas Therapeutics (LC8A) Financial Statements

2 Followers

Calliditas Therapeutics Financial Overview

Calliditas Therapeutics's market cap is currently ―. The company's EPS TTM is €-1.559; its P/E ratio is -22.57; Calliditas Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Jun 22Mar 22Sep 21Jun 21
Income Statement-
Total Revenue-kr 64.05Mkr 49.73Mkr 198.17M-
Gross Profit-kr 61.66Mkr 49.12Mkr 198.17M-
EBIT-----
EBITDA-----
Net Income Common Stockholders-kr -192.43Mkr -207.05Mkr 10.84Mkr -160.83M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentskr 973.73Mkr 846.80Mkr 825.41Mkr 1.16Bkr 709.31M
Total Assetskr 1.86Bkr 1.46Bkr 1.34Bkr 1.77Bkr 1.23B
Total Debtkr 27.09Mkr 20.64Mkr 21.86Mkr 0.00kr 0.00
Net Debtkr -946.64Mkr -826.16Mkr -803.55Mkr -1.16Bkr -709.31M
Total Liabilitieskr 1.52Bkr 737.20Mkr 473.20Mkr 478.14Mkr 260.85M
Stockholders Equitykr 334.81Mkr 721.09Mkr 871.14Mkr 1.26Bkr 937.84M
Cash Flow-
Free Cash Flow-kr -225.23Mkr -191.42Mkr -33.24Mkr -132.91M
Operating Cash Flow-kr -225.23Mkr -191.42Mkr -33.24Mkr -132.91M
Investing Cash Flow-kr -139.00Kkr -2.65Mkr -236.00Kkr -18.57M
Financing Cash Flow-kr 235.87Mkr 60.05Mkr 486.80Mkr -717.00K
Currency in SEK

Calliditas Therapeutics Earnings and Revenue History

Calliditas Therapeutics Debt to Assets

Calliditas Therapeutics Cash Flow

Calliditas Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis